EquityTips

EquityTips
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

free stock cash Tips

Wednesday, October 18, 2017

Equity Tips
STOCK FUTURES:

FUTURES INTRADAY:
BUY HDFCBANK  FUTURE  FIRST TGT 
SELL MARUTI FUTURE FINALT GT

OPTION
BUY RELIANCE CALL 900 FINAL TGT

STOCK CASH

STOCK CASH INTRADAY
SELL ICICI BANK COST EXIT
BUY RELIANCE IN CASH FINAL TGT

STOCK CASH PREMIUM:
BUY CENTURYTEX IN CASH ON HOLD 

STOCK SUPER CASH PREMIUM
BUY INFY IN CASH ON HOLD.
BUY IBVENTURE IN CASH ON HOLD.

OPTION STRATEGY
BUY TATAMTRDVR CALL  450 ON HOLD

HNI FUTURE CALL
SELL ZEEL FUTURE FINAL TGT YESTERDAY CALL

HNI OPTION CALL
BUY GAIL INDIA 500 OCT. CALL HOLD FOR TOMORROW
BUY AXIS BANK 460 PUT ON HOLD.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
Equity Tips

Equity benchmarks ended mildly lower on last day of Samvat 2073, dragged by banks after disappointing numbers from Axis Bank.
The 30-share BSE Sensex was down 24.81 points at 32,584.35 and the 50-share NSE Nifty fell 23.60 points to 10,210.90.

The market breadth was also in favour of declines as about 1,386 shares declined against 1,282 advancing shares on the BSE.

Axis Bank was biggest loser after sharp rise in slippages in Q2. The stock was down 6.5 percent.

HEADLINES OF THE DAY
Power Grid Corporation of India emerges as the successful bidder under TBCB.
Axis Bank to see sharp fall on dismal Q2 FY18 earnings.
UltraTech Cement Q2FY18 consolidated net profit declines 31% yoy.

The crucial resistance for Nifty spot is now seen at 10280 and above this 10375.Support for the immediate term is now placed at 10180 and next support will be 10100.

UPCOMING RESULTS: HAVELLS, HINDZINC, IBULHSGFIN, NOCIL, TINPLATE

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Tuesday, October 17, 2017

Equity Tips
Nifty breaks 10,200, Sensex falls 100 pts ; MAS Financial zooms 44%

Equity benchmarks opened lower on profit booking Wednesday, with the Sensex falling nearly 100 points, dragged by banks after disappointing numbers from Axis Bank.

The 30-share BSE Sensex was down 98.31 points to 32,510.85 and the 50-share NSE Nifty fell 28.10 points to 10,206.40.

The market breadth was balanced as about 497 shares advanced against 490 declining shares on the BSE.

Axis Bank was biggest loser after sharp rise in slippages in Q2. The stock was down 6.5 percent.

ICICI Bank, SBI, Cipla, Yes Bank and Zee Entertainment were early losers while Wipro, Kotak Mahindra Bank, TCS, ITC, Reliance Industries, Power Grid Corp and HCL Tech were early gainers.

The Indian rupee gained 9 paise against the US dollar in early trade. It has opened at 64.93 against the previous day's closing value of 65.02 per dollar.

Non-banking finance company MAS Financial Services is set to debut on exchanges today. The issue price is fixed at higher end of price band of Rs 456-459 per share.

Analysts expect the stock to list with a premium of Rs 150-200, given the strong subscription to the issue and strong financials of the company.

UltraTech Cement, which has Pan India presence, is expected to show a 38 percent decline year-on-year in standalone profit at Rs 370 crore but revenue from operations may grow 4 percent to Rs 6,380 crore.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Equity Tips
STOCK FUTURES:
FUTURES INTRADAY:
BUY BEML FUTURE  FINAL TGT 
BUY HINDPETRO FUTURE FINAL TGT

PREMIUM FUTURES:
BUY LUPIN FUTURE ON HOLD 
BUY ASIAN PAINT FUT 1 TGT AND HOLD

NIFTY FUTURES:
INDEX OPTION CALL

OPTION
BUY ASIAN PAINT  1200 CALL 1 TGT

OPTION PREMIUM
BUY LUPIN CALL 1080 OCT HOLD FOR TOMORROW

STOCK CASH

STOCK CASH INTRADAY
BUY PRAKASH IN CASH 2 TGT
BUY BAJAJ ELECTRIC  IN CASH 1 TGT
BUY BPCL IN CASH COST EXIT.

STOCK CASH PREMIUM:
BUY HAVELLS IN CASH 1 TGT
BUY BAJAJ AUTO IN CASH 1 TGT
BUY ACC IN CASH ON HOLD.

STOCK SUPER CASH PREMIUM
BUY JUBLFOOD IN CASH 1 TGT YESTERDAY CALL
BUY VAKRANGEE IN CASH 1 TGT
BUY INFY IN CASH ON HOLD.
BUY IBVENTURE IN CASH ON HOLD.

EQUITY KING CALL
BUY IOC FUTURE ON HOLD FOR TOMORROW

OPTION STRATEGY
BUY TATAMTRDVR CALL 450 ON HOLD

HNI CASH CALL
BUY DHFL IN CASH PARTIAL BOOKED AT 595

HNI FUTURE CALL
BUY BAJAJ AUTO FUTURE BOOKED 50% AND HOLD
SELL ZEEL FUTURE ON HOLD FOR TOMORROW

HNI OPTION CALL
BUY GAIL INDIA 500 OCT. CALL HOLD FOR TOMORROW
BUY CIPLA 630 CALL  ON HOLD

CPE FUTURE CALL
BUY CIPLA FUTURE BOOKED 50%  NEAR 635

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
Equity Tips
Equity benchmarks closed flat after consolidation but Nifty managed to end at record closing high.
The 30-share BSE Sensex was down 24.48 points at 32,609.16 and the 50-share NSE Nifty rose 3.60 points to 10,234.50.
The market breadth was almost balanced as about 1,367 shares advanced against 1,301 declining shares on the BSE.

Cipla, Bharti Airtel, Asian Paints, Bajaj Auto, Hero Motocorp, BPCL, HPCL and Indiabulls Housing were top gainers, up 1-4 percent whereas Axis Bank, Tata Motors, Bajaj Finance and Dr Reddy's Labs lost a percent each.

HEADLINES OF THE DAY
ACC Q3CY17 consolidated net profit rises 102.3% yoy.
MCX on Dhanteras launches India's First Commodity Options.
Auro Pharma receives USFDA approval for Esomeprazole Magnesium DR Capsules OTC.

The crucial resistance for Nifty spot is now seen at 10280 and above this 10375.Support for the immediate term is now placed at 10180 and next support will be 10100.

UPCOMING RESULTS: NIITTECH, ULTRACEMCO

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Monday, October 16, 2017

Equity Tips
Midcap outperforms Sensex; Reliance Capital, DHFL, BEML most active

Equity benchmarks opened mildly lower on profit booking Tuesday after the rally in three consecutive sessions.

The 30-share BSE Sensex was down 33.86 points at 32,599.78 and the 50-share NSE Nifty fell 15.10 points to 10,215.80.

Axis Bank, Reliance Industries, GAIL, Bajaj Auto, Yes Bank, IOC and Bharti Airtel were early gainers while Wipro, Bajaj Finance and BPCL were losers.

DCB Bank, JM Financial and Colgate were down 1.5-2.5 percent.

Tata Steel ruled out on Monday a flotation in the next two to three years of the planned merger of its European steel operations with those of ThyssenKrupp.

HDFC Standard Life Insurance Company has received capital markets regulator Securities and Exchange Board of India (SEBI)'s go ahead to raise an estimated Rs 7,500 crore through an initial public offering.

The insurance firm had filed draft papers with SEBI in August and obtained its "observations" on October 13, which is very necessary for any company to launch public offer, latest update with the markets watchdog showed.

The rupee dropped by 15 paise to 64.89 against the US currency today, breaking its six-day winning streak.

A spurt in dollar demand from importers amid sustained foreign fund outflows weighed on the rupee.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Saturday, October 14, 2017

Equity Tips

Indian pharmaceutical market (IPM) continued to be sluggish even in September month as the recovery from the supply chain disruption caused due to GST rollout in July seems to be a protracted one.

The industry grew at 2.8 percent in September with sales worth Rs 10,420 crore compared to 13.5 percent growth at Rs 10,136 crore during the same period last year, according to market research firm AIOCD-AWACS.
In the second quarter ended September the IPM grew 1 percent versus 14 percent in the same period previous year.

Second quarter generally happens to be a good quarter for Indian pharmaceutical market.

“The GST roll-out has impacted the second quarter; the incremental sales are at the lowest. Next quarter will be crucial,” the AIOCD-AWACS said in a statement.

Sales from anti-infective segment in September declined 3.5 percent, while dermatology, gastro intestinal and vitamins and mineral categories grew at 12.7 percent, 6.1 percent and 5.4 percent, respectively.
Major chronic therapy like anti-diabetic continuous to thrive high double-digit growth of 17.3 percent.

Seven out of the top 20 brands are from anti-diabetes.

Cardio segment has posted growth of 9.7 percent for the month, while central nervous system (CNS) grew 6.3 percent.

Respiratory segment, however, reported just 0.6 percent growth.Multinational companies grew at 3.9 percent for September 2017 which is faster than the Indian companies growth rate of 2.5 percent.

Domestic sales of Sun Pharma, India’s largest drug maker, rose 4.8 percent to Rs 3134 crore in the first of FY18. The company had a market share of 4.8 percent. Cipla came second with sales in India growing 0.2 percent at Rs 2650 crore during the first half.

Cadila Healthcare and Lupin were top growing companies in Indian domestic formulation market with growth rates of 8.1 percent at Rs 2291 crore and 7.3 percent to Rs 1938 crore, respectively.

In September quarter the pharma sector saw a volume stagnation at zero percent and price growth at –1.8 percent while the new products fared comparatively better at 2.8 percent.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Friday, October 13, 2017

Equity Tips
STOCK FUTURES:

FUTURES INTRADAY:
BUY AXIS BANK FUT  3RD TG
BUY HDFCBANK FUT  3RD TG

PREMIUM FUTURES:
BUY TATASTEEL FUT 3RD TG

NIFTY FUTURES:
BUY NIFTY FUTURE BUY CALL 2NDTG
BUY BANK NIFTY FUTURE 3RD TG

INDEX OPTION CALL
BUY BANKNIFTY 24400 CALL OCT FINAL TG

OPTION
BUY AXIS BANK 530 CAL OCT 3RD TG
BUY HDFCBANK 1840 CALL OCT BOOKED AT 30.85

OPTION PREMIUM
BUY TATASTEEL CALL710 OCT BUY CALL 2ND TG 
BUY LUPIN CALL 1080 OCT HOLD FOR TOMORROW

STOCK CASH

STOCK CASH INTRADAY
BUY INFRATEL IN CASH 1ST TG
BUY SOBHA IN CASH 2ND TG

STOCK CASH PREMIUM:
BUY HAVELLS IN CASH HOLD FOR TOMORROW
BUY KTKBANK IN CASH 1ST TG
RKFORGE BOUGHT ON 684 CALL ON FIREEEEEEEEEE 3RD TG ALMOST ACHIEVED MADE HIGH 714 , BOOK FULL PROFIT

STOCK SUPER CASH PREMIUM
BUY RAIN IN BUY CALL 2ND TG
BUY KTKBANK IN CASH 1ST TG ALMOST

EQUITY KING CALL
BUY AXIS BANK FUT HOLD FOR TOMORROW

OPTION STRATEGY
AXIS BANK CALL 530 BOUGHT NR 13 MADE HIGH 16.20 BOOK 50% PROFIT NR IT HOLD 50% FOR TGT 20

HNI CASH CALL
BUY RAIN IN HOLD FOR TOMORROW

HNI FUTURE CALL
BUY KARNATKA BANK FUTURES HOLD FOR TOMORROW

HNI OPTION CALL
BUY GAIL INDIA 500 OCT. CALL HOLD FOR TOMORROW
BUY BIOCON 370 OCT. CALL HOLD FOR TOMORROW

CPE  FUTURE CALL
SELL PNB FUTURES YESTERDAY 50% BOOKED 130.05
HAVELLS INDIA FUTURE WAS BOUGHT ON 10TH OCT. NR 534 MADE HIGH 545 NR FINAL TG 550 BOOK SUPER FULL PROFIT, CMP NR 540


Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
Equity Tips
Equity benchmarks closed sharply higher for the second consecutive session as investors cheered macro data and hopes raised for early resolution to telecom NPAs post telecom deals.

The 30-share BSE Sensex was up 250.47 points at 32,432.69 and the 50-share NSE Nifty rose 71.10 points to 10,167.50.
The market breadth was weak as about 1,431 shares declined against 1,293 advancing shares on the BSE.

Bharti Airtel was up 6 percent, Tata Teleservices up 9 percent and Tata Communications up 2 percent after Airtel decided to buy consumer telecom business of Tata Sons. Bharti Infratel was up 3 percent.

HEADLINES OF THE DAY
Tamil Nadu govt reduces entertainment tax; Inox Leisure stock zooms.
LIC Housing Fin files insolvency plea against DB Realty in NCLT.
Karnataka Bank Q2FY18 standalone net profit declines 24.6% yoy to Rs.93.4 crore.

The crucial resistance for Nifty spot is now seen at 10230 and above this 10350.Support for the immediate term is now placed at 10140 and next support will be 10060.

UPCOMING RESULTS: AVENUE SUPERMART, GRUH, BAJAJFINANCE, BAJAJFINSV, COLPAL, DCBBANK, DELTACORP, DHFL, FEDERAL BANK, STERLITE TECH, TEXMACO RAIL

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


Thursday, October 12, 2017

Equity Tips
Sensex up 150 pts, Nifty reclaims 10,150; RIL, Bharti Airtel lead

Equity benchmarks extended previous day's gains in opening, with the Nifty reclaiming 10,100 level and inching towards its record high level.

The rally was driven by Reliance Industries and Bharti Airtel.

The 30-share BSE Sensex was up 113.08 points at 32,295.30 and the 50-share NSE Nifty rose 31.40 points to 10,127.80.

Bharti Airtel was up 6 percent, Tata Teleservices up 9 percent and Tata Communications up 2 percent after Airtel decided to buy consumer telecom business of Tata Sons. Bharti Infratel was up 3 percent.

Reliance Industries gained a percent ahead of second quarter earnings later today.

Shriram EPC rallied 15 percent post bagging of multiple orders.

Bharat Financial and IndusInd Bank gained 0.4 percent each ahead of IndusInd's board meeting on Saturday.

Nifty Midcap was up 0.3 percent as about three shares advanced for every share falling on the NSE.

BHEL, EON Electric, LEEL Electricals, Indian Toners, Aimco Pesticides, Indo Count, Teamlease, NBCC, Adani Transmission, Cyient, MCX (ahead of Q2 earnings later today), Manappuram Finance and DHFL gained 1-10 percent.

The Indian rupee started off last day of the week at Rs 64.95 against the US dollar, continuing the appreciation further.

It gained 13 paise compared with previous closing value of 65.08 per dollar.

We at TCS are finding that the customers are much more specific about the projects that they are speaking about and they are working towards a strategy, a plan, Rajesh Gopinathan, CEO & MD said in an interview with CNBC-TV18.

Diligenta will start growing here onwards, the pipeline still continues to be good for Diligenta, he added.

It is difficult to call the timeframe but directionally we definitely see optimism returning, he further mentioned.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
Equity Tips
Cyient Q2 earnings better than estimates
Cyient Q2 earnings highlights:
Net Profit surges 29% at Rs109.7 crore
Revenue up 6% at Rs965.4 crore
EBITDA up 23.4% at Rs139.8 crore

Realty stocks in demand
Realty stocks after Finance Minister Arun Jaitley was quoted as stating that there is a strong case to bring real estate sector under the ambit of the Goods and Services Tax. Finance Minister Arun Jaitley was quoted as stating that there was a strong case to bring the real estate sector under the ambit of the goods and services tax (GST), identifying it as the one sector where maximum amount of tax evasion takes place. The matter will be discussed in the next meeting of the GST, which will be held on 9 November, in Guwahati, Jaitley reportedly said, while delivering a lecture at Harvard University.

IndusInd Bank Q2 profit in-line
IndusInd Bank Key Q2 highlights:
Net Profit at Rs880.10 crore
Net interest income up 25% at Rs1,821 crore Vs Rs1,460 crore (YOY)
Gross NPA at Rs1345.3 crore Vs Rs1271.7 crore (QoQ)
Net NPA at Rs537 crore Vs Rs508.3 crore (QoQ)
Net NPA 0.44% Vs 0.44% (QoQ)
Gross NPA 1.08% Vs 1.09% (QoQ)
Provisions at Rs293.7 crore Vs Rs213.9 crore (YoY); Vs Rs310 crore (QoQ)
Reports steady asset quality in Q2

Cadila gets USFDA nod for Desvenlafaxine extended-release tablets
Cadila Healthcare rose over 2% touching to Rs503, after U.S. drug regulator gave its final approval to market Desvenlafaxine extended-release tablets in strength of 50 and 100 mg in U.S.
The drug will be manufactured at company's Moraiya facility.

Hero MotoCorp sells over 20 lakh units in Q2 Sept 2017
Hero MotoCorp has announced that riding on robust sales of range of motorcycles and scooters, the company has set a new global record, clocking 20 lakh unit sales in the just-concluded Q2 September 2017.
This is the first time globally, that any two-wheeler company has crossed the 20 lakh sales mark in any quarter.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Wednesday, October 11, 2017

Equity Tips
Nifty holds 10,000, Midcap outperforms Sensex; Bharti Infratel up 4%

Equity benchmarks opened mildly higher on Thursday, seeing a rebound after yesterday's sell-off.

The 30-share BSE Sensex was up 60.51 points at 31,894.50 and the 50-share NSE Nifty gained 29 points at 10,013.80. About three shares advanced for every share falling on the BSE.

Bharti Infratel, GAIL, Sun Pharma, Vedanta, Reliance Industries, L&T, Hindalco Industries, IOC, BPCL, Lupin, TCS and HPCL were early gainers while Coal India, Bharti Airtel, Cipla, ICICI Bank and Asian Paints were losers.

The broader markets outperformed benchmarks in opening. Nifty Midcap was up 0.6 percent or 100 points.

Tata Consultancy Services, the country's largest software services provider, will announce its July-September quarter earnings today after market hours.

Profit after tax for the quarter is expected to increase 4 percent sequentially to Rs 6,183 crore and revenue may grow 2.6 percent to Rs 30,356 crore, according to average of estimates of analysts

The country's second-largest lender ICICI Bank is planning to raise USD 150 million in offshore borrowing this fiscal.

The bank said that the committee of executive directors, in a meeting held yesterday approved the offshore borrowing plan for 2017-18.

"The bank, under its GMTN (global medium-term note) programme, acting through its DIFC (Dubai) branch, tapped its existing 3.25 percent fixed rate notes maturing September 2022 for an amount of USD 150 million on private placement basis," ICICI Bank said in a regulatory filing

Share price of Zen Technologies surged 12 percent in morning on the back of export order win worth Rs 64 crore.

"It has signed the biggest export order till date of about Rs 64 crore," company said in release.

The contract is for live and virtual combat training systems against tough international competition.

This order is expected to be executed in the first half of next financial year 2018-19.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647